AR012853A1 - Formulacion inyectable transparente de compuesto anestesico - Google Patents

Formulacion inyectable transparente de compuesto anestesico

Info

Publication number
AR012853A1
AR012853A1 ARP980102379A ARP980102379A AR012853A1 AR 012853 A1 AR012853 A1 AR 012853A1 AR P980102379 A ARP980102379 A AR P980102379A AR P980102379 A ARP980102379 A AR P980102379A AR 012853 A1 AR012853 A1 AR 012853A1
Authority
AR
Argentina
Prior art keywords
injectable formulation
anesthetic compound
transparent
transparent injectable
anesthetic
Prior art date
Application number
ARP980102379A
Other languages
English (en)
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Publication of AR012853A1 publication Critical patent/AR012853A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulacion farmacéutica acuosa inyectable compuesta de: propofol, una sal aceptable farmacéuticamente de un ácido biliar y una lecitina.
ARP980102379A 1997-05-26 1998-05-22 Formulacion inyectable transparente de compuesto anestesico AR012853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.

Publications (1)

Publication Number Publication Date
AR012853A1 true AR012853A1 (es) 2000-11-22

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102379A AR012853A1 (es) 1997-05-26 1998-05-22 Formulacion inyectable transparente de compuesto anestesico

Country Status (23)

Country Link
US (1) US6326406B1 (es)
EP (1) EP0991405B1 (es)
JP (1) JP2001527577A (es)
KR (1) KR20010013011A (es)
CN (1) CN1268051A (es)
AR (1) AR012853A1 (es)
AT (1) ATE230984T1 (es)
AU (1) AU735020B2 (es)
BR (1) BR9809492A (es)
CA (1) CA2291261A1 (es)
CH (1) CH692322A5 (es)
DE (1) DE69810771D1 (es)
DZ (1) DZ2503A1 (es)
HU (1) HUP0002117A3 (es)
IN (1) IN187550B (es)
MY (1) MY132911A (es)
NO (1) NO995831L (es)
PA (1) PA8451701A1 (es)
PE (1) PE75299A1 (es)
PL (1) PL337026A1 (es)
TR (1) TR200000116T2 (es)
WO (1) WO1998053805A1 (es)
ZA (1) ZA984314B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
DE69922252T2 (de) * 1999-01-28 2005-12-01 Patel, Dinesh Shantilal Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
HUE048521T2 (hu) 2005-08-31 2020-08-28 Abraxis Bioscience Llc Gyengén vízoldékony gyógyszerészeti és antimikrobális hatóanyagokat tartalmazó keverékek
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
WO2010059727A1 (en) * 2008-11-20 2010-05-27 Teikoku Pharma Usa, Inc. Pyrazalone derivative formulations
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
CA3088017A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
GB1472793A (en) 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE3221579A1 (de) 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
WO1997010814A1 (en) 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
PL337026A1 (en) 2000-07-31
IN187550B (es) 2002-05-18
BR9809492A (pt) 2000-06-20
EP0991405B1 (en) 2003-01-15
HUP0002117A3 (en) 2001-04-28
KR20010013011A (ko) 2001-02-26
ATE230984T1 (de) 2003-02-15
NO995831D0 (no) 1999-11-26
HUP0002117A2 (hu) 2000-12-28
MY132911A (en) 2007-10-31
DZ2503A1 (fr) 2005-01-25
NO995831L (no) 2000-01-26
AU735020B2 (en) 2001-06-28
ZA984314B (en) 1998-12-08
EP0991405A1 (en) 2000-04-12
JP2001527577A (ja) 2001-12-25
CH692322A5 (it) 2002-05-15
US6326406B1 (en) 2001-12-04
DE69810771D1 (de) 2003-02-20
AU8209798A (en) 1998-12-30
CA2291261A1 (en) 1998-12-03
TR200000116T2 (tr) 2000-05-22
PA8451701A1 (es) 2000-05-24
WO1998053805A1 (en) 1998-12-03
CN1268051A (zh) 2000-09-27
PE75299A1 (es) 1999-08-26

Similar Documents

Publication Publication Date Title
AR012853A1 (es) Formulacion inyectable transparente de compuesto anestesico
HUP9803044A2 (hu) Ibuprofentartalmú készítmény
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
UY27586A1 (es) Cis- imidaxolinas
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
DE69824622D1 (de) Verwendung von vitamin d derivaten zur verstärkung der wirkung von zytotoxischen stoffen
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
ATE285241T1 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
BR0015188A (pt) Composições farmacêuticas
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
MX21452A (es) Preparaciones farmaceuticas que se administran en forma topica.
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
DE69534564D1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure-derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
AR032293A1 (es) Estuche farmaceutico
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
DE60019334D1 (de) Antivirale arznei
ATE239474T1 (de) Verwendung von levobupivacain
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant

Legal Events

Date Code Title Description
FA Abandonment or withdrawal